ReviewFrontiers in immunology2021

Inflammasome Signaling: A Novel Paradigm of Hub Platform in Innate Immunity for Cancer Immunology and Immunotherapy.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.